chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer who was the mother of the patient. The mother reported that her son stopped talking after receiving the MMR II booster shot. It's unknown if the patient had sought any medical attention. Upon internal review, autism was determined to be an other important medical event. Additional information has been requested.
This is a spontaneous report obtained from a contactable consumer. This consumer reported similar adverse event for three difference patients. This is the first of three reports. A male patient received PREVNAR 13 single dose on an unspecified date. Relevant medical history and concomitant medications were unknown. ON an unspecified date in NOV2013, while on PREVNAR 13, the patient experienced rash on arm, swelling on arm, inflammation on arm, fever and sores. Relevant laboratory data was unknown. Therapeutic measures taken in response to the events were unknown. At time of this report, clinical outcome of the events was unknown.   Follow-up (16JAN2014): Follow-up attempts completed. No further information expected.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-JUL-2016, the patient was vaccinated with a dose of improperly stored PROQUAD, lot # L023114, expiry date 24-DEC-2016, (dose and frequency not reported). No adverse effects reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. No additional information provided. This is one of two reports received from the same reporter. Additional information has been requested.
Arm starting hurting more.  Arm red around injection site with burning sensation.  Starting to swell more.
Itchy/scratchy throat, "weird" tongue sensation, dizziness only on 10/15/21 Rash on abdomen noted later on 10/15/21 and mostly resolved as of 10/20/21.  Pt self-treated- used rubbing alcohol on abdominal rash
received first shot of  moderna covid-19 on Jan 5th,2021. Had soreness and redness for two days and all was fine after that. On the morning of Jan 16 2021 I noticed a red spot the size of a half dollar where I received the vaccination. The spot was swollen, red, hot to the touch and a little tender. I went to ER and they marked the spot and said if it got bigger to return to the ER. On the morning of Jan.18, 2021 the spot was twice as big and more swollen, very red, hot to the touch and sore. My arm was also sore. I was diagnosed with cellulitis put on antibiotics ,cephalexin 500 mg , 4 times a time for ten days and told to make an appointment to see my primary care dr.
Headache, Sedation, Myalgia, Fever &  NauseaVomiting   Narrative:   Other Relevant History:
Vaccine ran down arm; Vaccine ran down arm; A spontaneous report was received from a consumer concerning a 76-years-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and some of the vaccine ran down his arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (Batch Number: 012M20A) intramuscularly in right arm for prophylaxis of COVID-19 infection.  On 22 Feb 2021, during administration some of the vaccine ran down the arm of patient.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, during administration some of the vaccine ran down the arm was considered resolved.; Reporter's Comments: This report refers to a case of incorrect dose administered and exposure via skin contact issue for mRNA-1273 (lot # 012M20A)  with no associated AEs reported
Heart Palpitations, labored breathing, night sweats, night mares, tingling/numbness in extremities, extreme lethargy, ringing in ears, dizziness, throat constriction, cognition problems, trouble speaking. Caused 2 visits to E.R.
The patient started running a fever of 101 within 12-24 hours of receiving her second covid vaccine and was suffering from altered mental status. She was transported via EMS where she was admitted until her d/c home on 2/20/21.
Lightheadedness and dizziness starting 10 minutes after the vaccine and lasting the rest of the day and into the next day.
Approximately 15 minutes after receiving 2nd vax, pt became pale, shaky, light headed, fingers stiffened. Improved upon blowing in paper bag.
sick and went to the hospital and had Covid pneumonia; sick and went to the hospital and had Covid pneumonia; This is a spontaneous report from a non-contactable consumer (patient).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 14Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient stated he took his 1st Pfizer vaccine dose on 14Jan2021 and then on 02Feb2021 he was sick and went to the hospital and had Covid pneumonia. He was in hospital until 09Feb2021, when he was discharged they said he should isolate for 7 days (until 16Feb2021). The patient stated that (Pharmacy name) came  on 24Feb2021 to give the 2nd vaccine dose and he was told by (Pharmacy name) that he had to wait 30 days to get his next shot. The patient asked when can he safely get the 2nd dose. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021364193 similar report from same reporter
I have severe swelling in both legs from knee to my feet,  severe itching and hives, legs have blistered and burst open. I also have a Blood clot in my lower left leg.  Have tried 2 kinds of antibiotics,  I am on Xarelto 10 mg tab for the blood clot
received first dose of Pfizer COVID vaccine then tested positive for COVID 19/Headache/Chills; received first dose of Pfizer COVID vaccine then tested positive for COVID 19/Headache/Chills; Dizziness; Joint pain all over the body; This is a spontaneous report from a contactable consumer (patient's husband). This consumer reported similar events for 2 patients (himself and wife). This is report 2 of 2, the report for the wife.   A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown), via an unspecified route of administration on 12Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient experienced headache, dizziness, joint pain all over the body and chills on 14Jan2021. The reporter himself and his wife got the shot on Tuesday the past week (12Jan2021), he was trying to figure out for a lot of the symptoms how long does it last, like the headache, dizziness, both him and his wife were experiencing this. His wife's symptoms began on Thursday 14Jan2021, she started getting sick with joint pain all over the body and chills. The second dose for both of them was scheduled on 02Feb2021. The patient then tested positive for COVID 19 on Wednesday, 20Jan2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021056969 similar report from same reporter
Initial information has been received from a physician concerning a baby patient of unknown age, unknown gender, unspecified pertinent medical history or drug reactions/allergies. On an unknown date, the patient was vaccinated with ROTATEQ, oral (duration, dose, frequency were not reported). No other co-suspect medications were reported. No concomitant medications were reported. It was reported that on an unknown date, after administering ROTATEQ to the "baby", the "baby" regurgitated. Treatment was not reported. The patient's outcome was unknown. Additional information has been requested.
This spontaneous report was received from a registered nurse referring to an unspecified patient of unknown age and gender. Information about the patient's medical history and concurrent conditions was not provided. On 07-JAN-2016, the patient was vaccinated with improperly stored doses of (Oka/Merck) VARIVAX lot #: L032391, expiration date: 26-AUG-2017 and M-M-R II (lot # L007216, expiration date: 03-MAR-2017) (administration routes were not provided). No concomitant therapies were reported, neither was any adverse effect. It was unknown if the patient sought medical attention. No product quality complaint was involved. This is one of two reports from the same reporter. Additional information has been requested.
The patient said they originally had flu like symptoms following the vaccine. Then 5 days later his arm was swollen and red with some heat coming from it.
Rash at site of injection and feverish arm; patient also had fever of 102.
shots gave me shingles, suspected vaccination failure; shingles; This serious case was reported by a nurse via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Hepatitis B vaccine with an associated reaction of herpes zoster (Hepatitis B shots in 90s gave the shingles to patient, refer case US2023AMR067343).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: shots gave me shingles, suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure and shingles to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR067343   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient reported that Shingles vaccine shots gave him or her shingles. The patient said did not do shots. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case was linked with case US2023AMR067343, reported by same reporter for different vaccine for same patient.; Sender's Comments:  US-GSK-US2023AMR067343:Same patient, same report, different vaccine
Patient refers that about 45 minutes after vaccination felt with frequents palpitations . This episodes repeat  during the course of the day. Note: I was notified  by patient after he was vaccinated, that he had plans to travel by airplane on Dec 18,2020.When patient call me notifying his symptoms I advised him to report to nearest emergency room for evaluation .
Moderna and Bivalent vaccines have undergone several temperature excursions and administered to patient; No Adverse Event; Patient was administered vaccine which had undergone several temperature excursions; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and administered to patient), POOR QUALITY PRODUCT ADMINISTERED (Patient was administered vaccine which had undergone several temperature excursions) and NO ADVERSE EVENT (No Adverse Event) in a 27-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     It was unknown whether patient has diagnosed/tested positive for COVID-19.     On 23-Sep-2022 at 1:50 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 23-Sep-2022 at 1:50 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered vaccine which had undergone several temperature excursions). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and administered to patient) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and administered to patient), POOR QUALITY PRODUCT ADMINISTERED (Patient was administered vaccine which had undergone several temperature excursions) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and administered to patient) and POOR QUALITY PRODUCT ADMINISTERED (Patient was administered vaccine which had undergone several temperature excursions).    No concomitant product use was reported.  The patient received previous 3 dose of vaccine intramuscular in deltoid.  Anatomical location of bivalent vaccine was reported as deltoid.  It was reported that the vaccines had undergone several temperature excursions in August 2022.  Refrigeration excursions identified and vaccine was housed in the units. There were excursions noted. Manufactures were notified and the state department and made aware of the situation. No adverse reactions reported for any patient at the time of report. Date vials moved from freezer to refrigerator was 07-Sep-2022 both monovalent vaccines.  No treatment drug information was provided.
(08/13 -25/2021)Sneezing and congestion with post nasal drip, no fever, Sinus headache, was determined as sinusitis. Amoxicillin, Benzonatate, Mucinex D. Breast Cancer discovered at end of May,
Patient sliding down in chair, became weak and slumped in chair, appears pale and sweaty. Vitals were all within normal limits. Patient was offered juice but she declined due to feeling nauseous. 10 minutes later patient was given orange juice and was advised to drink it slowly. Patient states that the fainting feeling comes in waves. After finishing the juice, color came back to her face but still complained of mild dizziness, and denies nausea. Patient appears anxious and fingers are shaking.  After some time, patient began to feel better and states her dizziness improved significantly. She was able to walk around and her dizziness did not return. 20 minutes later, all her symptoms subsided; fingers were no longer shaky, and she was no longer pale and sweaty.
This spontaneous report was received from a x-ray technician refers to herself who was exposed with ZOSTAVAX (Lot# reported as 0363AE, exp date 13-MAR-2013) into her eyes on an unspecified date. It was reported when she went to reconstitute the ZOSTAVAX liquid host out of the vial and got in her eyes and face when she was adding the Sterile Water Diluent (lot # H004947) to the vial of ZOSTAVAX on 03-AUG-2012. The x-ray technician reported that on 03-AUG-2012 she flushed her eyes with water for at least 15 minutes and now her eyes are red and irritated. At the time of reporting, the patient was not recovered. It was unknown whether the patient sought medical attention. PQC was filed. Additional information has been requested.
the results came back as positive for COVID-19/ COVID-19 PCR test; the results came back as positive for COVID-19/ COVID-19 PCR test; This is a spontaneous report from a Contactable Consumer or other non-health care professional (Patient).  A patient with unspecified age and gender has received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Batch no: not reported/ Lot number: EN6203) via unspecified route of administration on 11Mar2021 as dose 2, single for covid-19 immunization at health facility. The patient medical history and concomitant medication were not reported. Historical vaccine included patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Batch no: not reported/ Lot number: EL3247) via unspecified route of administration on 18Feb2021 as dose 1, single for covid-19 immunization. On 04Oct2021, Patient began experiencing fatigue, chills, fever, and a runny nose. Patient went to a local health clinic for a COVID-19 PCR test on 05Oct2021 and the results came back as positive for COVID-19 at afternoon on 06Oct2021. Patient was made aware of the positive COVID test at approximately 4:30 pm on 06Oct2021. No new symptoms have developed. Outcome of the event Covid-19 was unknown.
Patient has a mild contact dermatitis reaction at the injection site, redness and itch. No fever!
Pt rec'd ZOSTAVAX July 15 and on July 16 had headache. Then developed zoster on (L) left side of face
Stop having a menstrual cycle. Even though she is 54yrs old she was still having a normal menstrual cycle.
I tested positive for COVID-19. I had a headache and cough. I spoke to the doctor, and he said if it got worse give him a call or go to the ER. It did not get worse, and I got better in a week. I still have a cough.
After my son was born, he was taken from us and given unknown vaccines which we did not authorize.  He was over 10 pounds and beautifully healthy.  They came back later and said he was having trouble breathing and put him on a ventilator and he was in the NICU for 6 days.  He pulled out his tube twice; what newborn has the coordination or strength to do this?  Then they let us take him home.  He was having no trouble breathing after he was born and we are certain now that one or more of the vaccines he was giving caused this.  Six days of pain, suffering and anguish for all of us AND costing us thousands of dollars.  He was vaccine injured, we are sure of it.
Approximately 4 days after my second dose of Pfizer vaccine, I started noticing my left eye being swollen and constantly watering. 7 days post vaccine, I started having left sided facial weakness and droop. I was diagnosed with Bell's palsy by my Primary Care Physician today (8 days post vaccine).
Fever, chills, body aches, headache x 36 hours. Onset of autoimmune hepatitis on 1/24/22. I was told to report this to VAERS.
About 3 months after receiving H1N1, I developed swelling of the brain stem with many white areas in my brain. I had visual problems, weakness, confusion, very stiff neck, weight loss, headaches, extreme sleepiness. I was given high doses of steroids in my IV while I was in the hospital Feb.9, 2010 through Feb. 13, 2010. My doctors had never seen a MRI like mine, they sent it and many doctors did not know what could have caused this problem. I have had many other side effects in the past 3 months. Although I have had Addison's Disease since Nov. 2008, I only developed the brain problem after taking the H1N1 injection. I would like to know if anyone else has had this problem with the vaccine. Thank you.
Moderna vaccines on 1/20, 2/17/21 Positive for COVID by PCR on 12/15/21 Admitted to a local Hospital/clinic on 12/15/21 d/t right hip fracture, lives in HCF, found to be COVID positive on admission
Patient was administered different m-RNA vaccine (Pfizer) as a booster dose than he had received originally(Moderna).
Patient has COPD and is on 3L of oxygen at night. Patient has been having increasing shortness of breath on exertion as well as nasal congestion and cough for the last 2 weeks. Patient was admitted for sepsis secondary to COVID-19 pneumonia and NSTEMI.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 20-JUN-2012, the patient was vaccinated with the first dose of RECOMBIVAX HB, 2.5/0.5, injection (lot number not provided). On 20-JUL-2012, the patient was vaccinated with the second dose of RECOMBIVAX HB, 2.5/0.5, injection (lot number not provided). On an unspecified date, the physician (unspecified) discontinued the third dose of RECOMBIVAX HB because the patient was having unspecified cardiac issues. The reporter stated that the physician would now like to have the patient receive the third dose. At the time of the report, it was unknown if the patient received the third dose of RECOMBIVAX HB. The causal relationship between RECOMBIVAX HB and the event was unknown. The outcome of the event was unknown. Additional information has been requested.
got infected and tested positive for COVID; got infected and tested positive for COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Jan2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "got infected and tested positive for COVID". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) positive, notes: in the last couple weeks ago the family all tested positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Received 4 vaccines - asked to sit in chair x 15 min after HPV- stay next to pt admin (R) arm - after 2 min walk to chair to continue vaccine. Saw pt lean to (R) can get it lower to floor - after several seconds open eyes -talking no sign of injury with nurse x 10 min - given Panar Barrett wash - Denies having anything - no sign of injury. Ambulated to school nurse office. Dad called and made aware to call  PM and to  doctor. Pt denied any problems. 3 friends gave lunch stayed with in office -"Im fine". 5/17/10 called and spoke with pt Dad. 15:40 - Pt's fine "120" didn't feel well @ 1st and pt snapped out of it She is fine".
Facial numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Facial numbness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Facial numbness). At the time of the report, HYPOAESTHESIA (Facial numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided  No treatment information was reported